In May 2024, the Brazilian Senate Committee on Science, Technology, Innovation, and Informatics hosted two public hearings to discuss implementing Regulatory Data Protection (RDP) for pharmaceutical products of human use.
Related Keywords
Japan , Canada , Rio De Janeiro , Estado Do Rio , Brazil , Costa Rica , Colombia , Chile , United States , Copenhagen , Køavn , Denmark , Mexico , Peru , America , Brazilian , Daniela Fernandes , Leandro Pedron , Thiago Vicente , Emanuella Kunz , Marcela Vieira , Izalci Lucas , Ricardo Lobato Torres , Renato Porto , Julia Paranhos , Senate Hearings , European Union , Izalci Lucas Liberal Party , Brazilian Senate Committee On Science , Brazilian Association Of Generic , Biosimilar Medicines Industries , Anvisa National Health Surveillance Agency , Brazilian Congress , Interfarma Association Of Pharmaceutical Companies , World Trade Organization , Economic Innovation Group , University Of Rio De Janeiro , Regulatory Data Protection Brazilian Senate , Health System , Programs Of The Ministry Science , Brazilian Patent Office , Data Protection , Brazilian Senate Committee , Regulatory Data Protection , Senator Izalci Lucas , Liberal Party , Research Based Pharmaceutical Companies , National Health Surveillance Agency , Senator Hiran Gon , Federal University , Regional Advocacy Advisor , Latin America , Doctors Without Borders , Trade Related Aspects , Intellectual Property Rights , Brazilian Association , Cristina De Abreu , Quality Management , Intellectual Property , Thematic Programs , Strategic Policies , Unified Health System ,
comparemela.com © 2020. All Rights Reserved.